Literature DB >> 25040173

A TALEN-based specific transcript knock-down of PIWIL2 suppresses cell growth in HepG2 tumor cell.

Y Chen1, W Hu, Y Lu, S Jiang, C Li, J Chen, D Tao, Y Liu, Y Yang, Y Ma.   

Abstract

OBJECTIVES: PIWIL2 is widely expressed in various tumours and implicated in playing a role in tumourigenesis. For a more thorough study of PIWIL2 functions in tumour cells, we aimed to establish PIWIL2-specific transcript knock-down/knockout HepG2 cell lines using transcription activator-like effector nuclease (TALEN) technology. Furthermore, we proposed to use the cell models to explore PIWIL2 functions in TGF-β signalling in HepG2 cells. HepG2s are human hepatocellular carcinoma cells.
MATERIALS AND METHODS: We established PIWIL2 knock-down or knock-out cell lines in HepG2 using TALEN technology. Next, we sought to use the cell line models to investigate effects of full length PIWIL2-specific transcripts in cell proliferation induced by TGF-β.
RESULTS: First, we established PIWIL2-specific transcript mono-allele and bi-allele knockout HepG2 cell lines. By using the cell line models, we found that specific transcript knockdown of full length PIWIL2 can suppress cell proliferation, while ectopic expression of PIWIL2 enhanced proliferation of HepG2 by suppressing the TGF-β pathway. Furthermore, we demonstrated that PIWIL2 can interact with HSP90 to prevent formation of HSP90-TβR complexes, which promote degradation of TβRs.
CONCLUSIONS: Taken together, our study revealed critical negative regulation of TGF-β signalling by PIWIL2 in HepG2 tumour cells, and provided an effective strategy to study specific gene transcript functions in cells.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25040173      PMCID: PMC6495709          DOI: 10.1111/cpr.12120

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  40 in total

Review 1.  The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis.

Authors:  Michelle A Carmell; Zhenyu Xuan; Michael Q Zhang; Gregory J Hannon
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

Review 2.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer.

Authors:  Peter M Siegel; Joan Massagué
Journal:  Nat Rev Cancer       Date:  2003-11       Impact factor: 60.716

Review 3.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

Authors:  Laurence Levy; Caroline S Hill
Journal:  Cytokine Growth Factor Rev       Date:  2005-11-23       Impact factor: 7.638

4.  Piwil2 is expressed in various stages of breast cancers and has the potential to be used as a novel biomarker.

Authors:  James J Liu; Rulong Shen; Li Chen; Yin Ye; Gang He; Keding Hua; David Jarjoura; Toru Nakano; Ganju K Ramesh; Charles L Shapiro; Sanford H Barsky; Jian-Xin Gao
Journal:  Int J Clin Exp Pathol       Date:  2010-03-20

5.  An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster.

Authors:  Hang Yin; Haifan Lin
Journal:  Nature       Date:  2007-10-21       Impact factor: 49.962

6.  Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis.

Authors:  Yin Ye; De-Tao Yin; Li Chen; Quansheng Zhou; Rulong Shen; Gang He; Qingtao Yan; Zhenyu Tong; Andrew C Issekutz; Charles L Shapiro; Sanford H Barsky; Haifan Lin; Jian-Jian Li; Jian-Xin Gao
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

7.  Critical regulation of TGFbeta signaling by Hsp90.

Authors:  Katharine H Wrighton; Xia Lin; Xin-Hua Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-30       Impact factor: 11.205

8.  Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.

Authors:  D M Bissell; S S Wang; W R Jarnagin; F J Roll
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Zili inhibits transforming growth factor-beta signaling by interacting with Smad4.

Authors:  Huaqin Sun; Dan Li; Shu Chen; Yanyan Liu; Xiaolin Liao; Wenqian Deng; Na Li; Mei Zeng; Dachang Tao; Yongxin Ma
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

10.  TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.

Authors:  Xiaoxin Mu; Shu Lin; Junhua Yang; Chen Chen; Yun Chen; Maryanne C Herzig; Kenneth Washburn; Glenn A Halff; Christi A Walter; Beicheng Sun; Lu-Zhe Sun
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  8 in total

1.  A novel tumor-specific broad-spectral monoclonal antibody to PL2L60 is highly effective for the treatment of various types of cancers from human and mouse.

Authors:  Hong-Min Lu; Yu-Jie Fu; Ning Liu; Wu-Yan Xia; Hai-Yan Chen; Meng-Yao Liu; Lin-Feng Li; Jian-Xin Gao
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 2.  PAQR3: a novel tumor suppressor gene.

Authors:  Xin Yu; Zheng Li; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

3.  miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.

Authors:  Guixing Jiang; Yunfu Cui; Xin Yu; Zhengrong Wu; Guoping Ding; Liping Cao
Journal:  Oncotarget       Date:  2015-04-20

4.  An unusual intragenic promoter of PIWIL2 contributes to aberrant activation of oncogenic PL2L60.

Authors:  Shan-Shan Liu; Ning Liu; Meng-Yao Liu; Lei Sun; Wu-Yan Xia; Hong-Min Lu; Yu-Jie Fu; Guo-Liang Yang; Juan-Jie Bo; Xiao-Xing Liu; Haizhong Feng; Hailong Wu; Lin-Feng Li; Jian-Xin Gao
Journal:  Oncotarget       Date:  2017-07-11

Review 5.  Contextual Regulation of TGF-β Signaling in Liver Cancer.

Authors:  Shuo Tu; Wei Huang; Chunhong Huang; Zhijun Luo; Xiaohua Yan
Journal:  Cells       Date:  2019-10-11       Impact factor: 6.600

6.  P-element Induced WImpy protein-like RNA-mediated gene silencing 2 regulates tumor cell progression, apoptosis, and metastasis in oral squamous cell carcinoma.

Authors:  Sen Zhou; Song Yang; Fang Li; Jingying Hou; Hong Chang
Journal:  J Int Med Res       Date:  2021-11       Impact factor: 1.671

7.  Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating the stability and activity of BMAL1 and CLOCK.

Authors:  Yilu Lu; Xulei Zheng; Wei Hu; Shasha Bian; Zhiwei Zhang; Dachang Tao; Yunqiang Liu; Yongxin Ma
Journal:  Oncotarget       Date:  2017-07-04

8.  Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma.

Authors:  Benyuan Deng; Min Yang; Ming Wang; Zhongwu Liu
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.